FMP
Forte Biosciences, Inc.
FBRX
NASDAQ
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
5.02 USD
0.07 (1.39%)